Cargando…

Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia

AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statis...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrushevska, Tatjana, Velik Stefanovska, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877776/
https://www.ncbi.nlm.nih.gov/pubmed/27275214
http://dx.doi.org/10.3889/oamjms.2015.004
_version_ 1782433443845505024
author Petrushevska, Tatjana
Velik Stefanovska, Vesna
author_facet Petrushevska, Tatjana
Velik Stefanovska, Vesna
author_sort Petrushevska, Tatjana
collection PubMed
description AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statistical Reports of the United Nations regarding the consumption of psychotropic substances; data from the Ministry of Health associated with the use of benzodiazepines (BZD), derived from reports of Ministry of Health stakeholders; Data extracted from the database of the Ministry of Health in the electronic database “My term” and Analysis of reports of Health Insurance Fund. RESULTS: The analysis for the period 2003-2013 showed that the most consumed drug in MKD from the group of BZD is Diazepam, with 54.8 and predominantly is use of diazepam of 5 mg with 59 %. According to the Health Insurance Fund, Diazepam is second most prescribed medicaments of all medicaments with marketing authorization in MKD. CONCLUSIONS: The analysis shows that the use of BZD in MKD is particularly high. Limited number of studies was performed for this kind of drugs relating to their effects; differences in use between genders; adult population. There is need for additional focused research that will contribute to developing a full picture of the situation.
format Online
Article
Text
id pubmed-4877776
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Institute of Immunobiology and Human Genetics
record_format MEDLINE/PubMed
spelling pubmed-48777762016-06-06 Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia Petrushevska, Tatjana Velik Stefanovska, Vesna Open Access Maced J Med Sci Public Health AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statistical Reports of the United Nations regarding the consumption of psychotropic substances; data from the Ministry of Health associated with the use of benzodiazepines (BZD), derived from reports of Ministry of Health stakeholders; Data extracted from the database of the Ministry of Health in the electronic database “My term” and Analysis of reports of Health Insurance Fund. RESULTS: The analysis for the period 2003-2013 showed that the most consumed drug in MKD from the group of BZD is Diazepam, with 54.8 and predominantly is use of diazepam of 5 mg with 59 %. According to the Health Insurance Fund, Diazepam is second most prescribed medicaments of all medicaments with marketing authorization in MKD. CONCLUSIONS: The analysis shows that the use of BZD in MKD is particularly high. Limited number of studies was performed for this kind of drugs relating to their effects; differences in use between genders; adult population. There is need for additional focused research that will contribute to developing a full picture of the situation. Institute of Immunobiology and Human Genetics 2015-03-15 2014-12-24 /pmc/articles/PMC4877776/ /pubmed/27275214 http://dx.doi.org/10.3889/oamjms.2015.004 Text en Copyright: © 2015 Tatjana Petrushevska, Vesna Velik Stefanovska. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Public Health
Petrushevska, Tatjana
Velik Stefanovska, Vesna
Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title_full Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title_fullStr Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title_full_unstemmed Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title_short Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
title_sort use of medicines from the group of benzodiazepines in the period of 2003-2013 year in the republic of macedonia
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877776/
https://www.ncbi.nlm.nih.gov/pubmed/27275214
http://dx.doi.org/10.3889/oamjms.2015.004
work_keys_str_mv AT petrushevskatatjana useofmedicinesfromthegroupofbenzodiazepinesintheperiodof20032013yearintherepublicofmacedonia
AT velikstefanovskavesna useofmedicinesfromthegroupofbenzodiazepinesintheperiodof20032013yearintherepublicofmacedonia